IceCure Medical Ltd.: stockholders equity
Stockholders equity for IceCure Medical Ltd. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All IceCure Medical Ltd. financial histories
What this measure means
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
Exact concept: us-gaap:StockholdersEquity. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2019-12-31 to 2025-12-31. The SEC response was captured on 2026-09-20.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 9,051,000 | USD | 2026-03-17 | 20-F · 0001213900-26-028684 |
| At date | 2024-12-31 | 6,901,000 | USD | 2026-03-17 | 20-F · 0001213900-26-028684 |
| At date | 2023-12-31 | 12,163,000 | USD | 2026-03-17 | 20-F · 0001213900-26-028684 |
| At date | 2022-12-31 | 25,422,000 | USD | 2026-03-17 | 20-F · 0001213900-26-028684 |
| At date | 2021-12-31 | 26,958,000 | USD | 2025-03-27 | 20-F · 0001013762-25-003012 |
| At date | 2020-12-31 | 5,648,000 | USD | 2024-04-03 | 20-F · 0001213900-24-029586 |
| At date | 2019-12-31 | 3,291,000 | USD | 2023-03-29 | 20-F · 0001213900-23-023867 |
Related financial histories
- IceCure Medical Ltd.: total assets
- IceCure Medical Ltd.: cash and cash equivalents
- IceCure Medical Ltd.: net income or loss
- IceCure Medical Ltd.: operating cash flow
- IceCure Medical Ltd.: capital expenditure payments
- IceCure Medical Ltd.: revenue
- IceCure Medical Ltd.: financing cash flow
- IceCure Medical Ltd.: investing cash flow
- IceCure Medical Ltd.: retained earnings or deficit
- IceCure Medical Ltd.: basic weighted-average shares
- IceCure Medical Ltd.: diluted weighted-average shares
- IceCure Medical Ltd.: basic earnings per share
- IceCure Medical Ltd.: diluted earnings per share
- IceCure Medical Ltd.: net property, plant and equipment
- IceCure Medical Ltd.: share-based compensation expense
- IceCure Medical Ltd.: operating income or loss
- IceCure Medical Ltd.: current assets
- IceCure Medical Ltd.: current liabilities
- IceCure Medical Ltd.: current accounts payable
- IceCure Medical Ltd.: net current accounts receivable
- IceCure Medical Ltd.: net inventory
- IceCure Medical Ltd.: gross profit
- IceCure Medical Ltd.: cost of revenue
- IceCure Medical Ltd.: selling, general and administrative expense
- IceCure Medical Ltd.: research and development expense
- IceCure Medical Ltd.: common shares outstanding
- IceCure Medical Ltd.: cash including restricted cash
- IceCure Medical Ltd.: additional paid-in capital
- IceCure Medical Ltd.: total equity including noncontrolling interests
- IceCure Medical Ltd.: operating lease right-of-use asset
- IceCure Medical Ltd.: operating lease liability
- IceCure Medical Ltd.: gross property, plant and equipment
- IceCure Medical Ltd.: accumulated depreciation on property, plant and equipment
- IceCure Medical Ltd.: prepaid expenses and other current assets
- IceCure Medical Ltd.: profit or loss including noncontrolling interests
- IceCure Medical Ltd.: general and administrative expense
- IceCure Medical Ltd.: depreciation expense
- IceCure Medical Ltd.: nonoperating income or expense
- IceCure Medical Ltd.: proceeds from issuing common stock
- IceCure Medical Ltd.: operating lease payments
- IceCure Medical Ltd.: change in accounts receivable
- IceCure Medical Ltd.: change in inventories
Inspect the source
- Entity
- IceCure Medical Ltd. / CIK 0001584371
- Captured
- 2026-09-20T09:23:08.891Z
- SEC response SHA-256
69fc07cf0ed1e8ececccce3210c1ad2159bbe4ba65cf61ab2db13c22606b3528
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001584371.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))